Can you imagine having an accurate, personalized and real-time diagnosis just by taking a sample of your body? This is the goal of team of the Monterrey Institute of Technology and Higher Education (ITESM), who develop a device with the goal of offering tailored cardiovascular diagnoses. The device detects changes in the production of molecules associated with coronary diseases thanks to an electrochemical biosensor.
“The main objective is to study the effect of mechanical stress on the production of nitric oxide, a key molecule in the development of diseases such as atherosclerosis,” said Gustavo Hernández, one of the researchers of the study.
Hernández, PhD student in Biotechnology, explained that with this personalized medicine, the treatment of diseases could be designed according to the genetic characteristics of each individual. The objective is to have more accurate diagnoses that would allow doctors to choose the treatment that generates the best response to the patient.
How is the proccess?
The process begins by obtaining a sample of the patient to obtain an immediate result, similarly to measurements of blood sugar with a glucometer.
The sample is analyzed to then make an evaluation of the best available therapy, which is finally applied to the patient.
ITESM Strategic Focus Bioprocess Research Group is the forerunner of this research, in collaboration with other universities, such as the Massachusetts Institute of Technology (MIT).
This project has generated scientific publications on electrochemical biosensors, biomaterials, cardiac tissue engineering and development of technologies for disease diagnosis.
“We still face some challenges that must be overcome, especially from the technological point of view, since personalized medicine represents an opportunity for the development of new devices for the diagnosis of diseases,” says Hernández.
However, the researcher hopes that the development of this and other innovative technologies will improve the diagnosis of different diseases.
“This would positively improve the experience and quality of life of users of the health system, even in remote communities.”
Source: Agencia ID